Scientists target enzyme and halt spread of deadly breast cancer tumours with novel drugs
Researchers at the BC Cancer Agency discover a significant connection between the spread of breast cancer and a natural enzyme, called CA9. This discovery …
Grace SplitMango
New breast cancer care coordinator helps women navigate through cancer diagnosis and treatment
March 15, 2011, Abbotsford, BC – Breast cancer patients being treated at the BC Cancer Agency’s Abbotsford Centre and in the eastern Fraser Valley …
Researchers discover how cancer cheats immune system
March 2, 2011, Vancouver, BC – BC Cancer Agency scientists have discovered that a single gene, CIITA, is implicated in almost 40 per cent …
Scientists discover first breast cancer ‘oncogene’ for five years
Dr. Sam Aparicio, the Agency’s head of breast cancer research, co-led a UK-based study that discovered a new cancer-causing gene, ZNF703, that when …
BC Cancer Agency seeks student researchers
February 11, 2011, Victoria, BC – Brad Nelson, head of the Deeley Research Centre at BC Cancer - Victoria, had lunch at Oxford University recently with …
Southern Interior residents invited to take part in major cancer prevention study
January 5, 2011, Kelowna, BC – The BC Generations Project came to the Southern Interior this morning, and with it came a call for …
B.C.’s cancer survival rates bode well in international comparison
December 21, 2010, Vancouver, BC – B.C. has encouraging survival outcomes in breast and ovarian cancer, taking top rank in a comprehensive data study …
Record $2.6 million raised at BC Cancer Foundation’s Inspiration Gala
October 29, 2010, Vancouver, BC – The capacity crowd of 400 dinner guests had philanthropy on their minds last night as they donated a …
Scientists identify the P-cadherin protein as a prognostic biomarker in breast cancer
Researchers from the BC Cancer Agency and from Pfizer oncology analyzed the expression of the P-cadherin protein in breast cancer and found that over-expression …
Scientists uncover strategy to effectively target drug resistant childhood cancers
Researchers used gene silencing to identify MST1R – a complimentary drug target for IGF1R therapy which, when silenced, boosts the efficacy of existing cancer …